RXRX NASDAQ
Recursion Pharmaceuticals, Inc.
1W: +10.2%
1M: +21.9%
3M: +4.0%
YTD: -1.9%
1Y: -19.2%
3Y: -47.0%
5Y: -83.2%
$4.12
+0.05 (+1.23%)
Weekly Expected Move ±12.2%
$3
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — RXRX
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (18)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 59.3 | 65.5 | 70.8 | 65.2 | SEC ↗ |
| 2026-03-31 | 10-Q | 58.5 | 66.3 | 68.0 | 64.2 | SEC ↗ |
| 2025-12-31 | 10-K | 60.5 | 63.3 | 60.6 | 61.5 | SEC ↗ |
| 2025-09-30 | 10-Q | 58.4 | 67.0 | 69.7 | 65.0 | SEC ↗ |
| 2025-06-30 | 10-Q | 61.8 | 64.5 | 68.0 | 64.8 | SEC ↗ |
| 2025-03-31 | 10-Q | 73.7 | 64.6 | 71.8 | 70.0 | SEC ↗ |
| 2024-12-31 | 10-K | 64.2 | 63.5 | 60.9 | 62.9 | SEC ↗ |
| 2024-09-30 | 10-Q | 65.7 | 65.0 | 73.5 | 68.1 | SEC ↗ |
| 2024-06-30 | 10-Q | 61.8 | 65.6 | 64.7 | 64.0 | SEC ↗ |
| 2024-03-31 | 10-Q | 63.7 | 66.0 | 69.4 | 66.4 | SEC ↗ |
| 2023-09-30 | 10-Q | 62.6 | 66.3 | 72.6 | 67.2 | SEC ↗ |
| 2023-06-30 | 10-Q | 72.7 | 68.8 | 78.2 | 73.2 | SEC ↗ |
| 2023-03-31 | 10-Q | 79.3 | 68.8 | 80.8 | 76.3 | SEC ↗ |
| 2022-12-31 | 10-K | 62.1 | 64.5 | 62.1 | 62.9 | SEC ↗ |
| 2022-09-30 | 10-Q | 80.6 | 66.2 | 80.8 | 75.9 | SEC ↗ |
| 2022-06-30 | 10-Q | 87.0 | 68.3 | 72.4 | 75.9 | SEC ↗ |
| 2022-03-31 | 10-Q | 87.8 | 68.1 | 80.0 | 78.6 | SEC ↗ |
| 2021-12-31 | 10-K | 60.4 | 62.7 | 62.1 | 61.7 | SEC ↗ |